Skip to main content
logo
Greenwich LifeSciences, Inc. (GLSI)
NASDAQ: GLSI · Real-Time Price · USD
16.72
+1.55 (10.18%)
Nov 9, 2026, 3:12 PM EST - Market open

Greenwich LifeSciences Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-22.47-19.36-17.41-8.89-7.83-4.57
Depreciation & Amortization
-00000
Stock-Based Compensation
6.746.87.252.381.740.66
Change in Accounts Payable
2.92.072.550.04--0.53
Change in Other Net Operating Assets
0.340.570.34-0-0.120.14
Operating Cash Flow
-12.49-9.91-7.27-6.48-6.2-4.29
Operating Cash Flow Growth
------

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Short-Term Debt Repaid
------0.28
Total Debt Repaid
------0.28
Net Debt Issued (Repaid)
------0.28
Issuance of Common Stock
18.24124.37--3.36
Repurchase of Common Stock
-----7.54-
Other Financing Activities
------0.25
Financing Cash Flow
18.24124.37--7.542.84

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Cash Flow
5.752.09-2.9-6.48-13.74-1.46

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Levered Free Cash Flow
-3.34-2.71-0.88-3.42-3.4-2.59
Unlevered Free Cash Flow
-3.34-2.71-0.88-3.42-3.4-2.59

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Change in Working Capital
3.242.642.890.03-0.12-0.39
SEC Filings: 10-K · 10-Q